Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Abu Ali, Galeb S ^a   Ouellette, Lindsey M ^a   Henderson, Scott T ^a   Lacher, David W ^b   Riordan, James T ^a   Whittam, Thomas S ^a   Manning, Shannon D ^a,c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI SECRETED PROTEIN A; ESCHERICHIA COLI SECRETED PROTEIN B; SHIGA TOXIN; SIGMA FACTOR RPOS; TRANSCRIPTOME; UNCLASSIFIED DRUG; VEROTOXIN 2; VIRULENCE FACTOR;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELL ADHESION; CELL INVASION; CLADISTICS; CONTROLLED STUDY; COW; ENTEROHEMORRHAGIC ESCHERICHIA COLI; EPITHELIUM CELL; GENE EXPRESSION; INCUBATION TIME; NONHUMAN; PATHOGENICITY ISLAND; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; UPREGULATION; ANIMAL; BACTERIAL GENE; BACTERIAL GENOME; CATTLE; CELL CULTURE; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEMOLYTIC UREMIC SYNDROME; HUMAN; MICROBIOLOGY; PATHOGENICITY; VIRULENCE;

BOVINAE; ESCHERICHIA COLI;

ANIMALS; CATTLE; CELLS, CULTURED; EPITHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENOME, BACTERIAL; HEMOLYTIC-UREMIC SYNDROME; HUMANS; VIRULENCE;

EID: 77955260864     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010167     Document Type: Article

References (62)

1. Rangel JM, Sparling PH, Crowe C, Griffin PM, Swerdlow DL (2005) Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg Infect Dis 11: 603-609.
2. Frenzen PD, Drake A, Angulo FJ (2005) Economic cost of illness due to Escherichia coli O157 infections in the United States. J Food Prot 68: 2623-2630.
3. Tobe T, Beatson SA, Taniguchi H, Abe H, Bailey CM, et al. (2006) An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A 103: 14941-14946.
4. Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123-140.
5. Manning SD, Motiwala AS, Springman AC, Qi W, Lacher DW, et al. (2008) Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci U S A 105: 4868-4873.
6. Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, et al. (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37: 497-503.
7. Jelacic JK, Damrow T, Chen GS, Jelacic S, Bielaszewska M, et al. (2003) Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J Infect Dis 188: 719-729.
8. Persson S, Olsen KE, Ethelberg S, Scheutz F (2007) Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol 45: 2020-2024.
9. Ostroff SM, Kobayashi JM, Lewis JH (1989) Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. JAMA 262: 355-359.
10. Ostroff SM, Tarr PI, Neill MA, Lewis JH, Hargrett-Bean N, et al. (1989) Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis 160: 994-998.
11. Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, et al. (2002) Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 185: 74-84.
12. Hayashi T, Makino K, Ohnishi M, Kurokawa K, Ishii K, et al. (2001) Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res 8: 11-22.
13. Abu-Ali GS, Ouellette LM, Henderson ST, Whittam TS, Manning SD (2010) Differences in adherence and virulence gene expression between two outbreak strains of enterohemorrhagic Escherichia coli O157:H7. Microbiology 156: 408-419.
14. Eaton KA, Friedman DI, Francis GJ, Tyler JS, Young VB, et al. (2008) Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germfree mice. Infect Immun 76: 3054-3063.
15. Vanaja SK, Springman AC, Besser TE, Whittam TS, Manning SD (2010) Differential expression of virulence and stress fitness genes between Escherichia coli O157:H7 strains with clinical or bovine-biased genotypes. Appl Environ Microbiol 76: 60-68.
16. Strauch E, Hammerl JA, Konietzny A, Schneiker-Bekel S, Arnold W, et al. (2008) Bacteriophage 2851 is a prototype phage for dissemination of the Shiga toxin variant gene 2c in Escherichia coli O157:H7. Infect Immun 76: 5466-5477.
17. McCarthy DJ, Smyth GK (2009) Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics 25: 765-771.
18. Jandu N, Ho NK, Donato KA, Karmali MA, Mascarenhas M, et al. (2009) Enterohemorrhagic Escherichia coli O157:H7 gene expression profiling in response to growth in the presence of host epithelia. PLoS One 4: e4889.
19. Garmendia J, Frankel G, Crepin VF (2005) Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect Immun 73: 2573-2585.
20. Koitabashi T, Vuddhakul V, Radu S, Morigaki T, Asai N, et al. (2006) Genetic characterization of Escherichia coli O157: H7/- strains carrying the stx2 gene but not producing Shiga toxin 2. Microbiol Immunol 50: 135-148.
21. Wagner PL, Neely MN, Zhang X, Acheson DW, Waldor MK, et al. (2001) Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain. J Bacteriol 183: 2081-2085.
22. Spears KJ, Roe AJ, Gally DL (2006) A comparison of enteropathogenic and enterohaemorrhagic Escherichia coli pathogenesis. FEMS Microbiol Lett 255: 187-202.
23. Iyoda S, Watanabe H (2005) ClpXP protease controls expression of the type III protein secretion system through regulation of RpoS and GrlR levels in enterohemorrhagic Escherichia coli. J Bacteriol 187: 4086-4094.
24. Tomoyasu T, Takaya A, Handa Y, Karata K, Yamamoto T (2005) ClpXP controls the expression of LEE genes in enterohaemorrhagic Escherichia coli. FEMS Microbiol Lett 253: 59-66.
25. Deng W, Puente JL, Gruenheid S, Li Y, Vallance BA, et al. (2004) Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci U S A 101: 3597-3602.
26. Tatsuno I, Horie M, Abe H, Miki T, Makino K, et al. (2001) ToxB gene on pO157 of enterohemorrhagic Escherichia coli O157:H7 is required for full epithelial cell adherence phenotype. Infect Immun 69: 6660-6669.
27. Stevens MP, Roe AJ, Vlisidou I, van Diemen PM, La Ragione RM, et al. (2004) Mutation of toxB and a truncated version of the efa-1 gene in Escherichia coli O157:H7 influences the expression and secretion of locus of enterocyte effacement-encoded proteins but not intestinal colonization in calves or sheep. Infect Immun 72: 5402-5411.
28. Dahan S, Knutton S, Shaw RK, Crepin VF, Dougan G, et al. (2004) Transcriptome of enterohemorrhagic Escherichia coli O157 adhering to eukaryotic plasma membranes. Infect Immun 72: 5452-5459.
29. Kim Y, Oh S, Park S, Kim SH (2009) Interactive transcriptome analysis of enterohemorrhagic Escherichia coli (EHEC) O157:H7 and intestinal epithelial HT-29 cells after bacterial attachment. Int J Food Microbiol 131: 224-232.
30. Laing CR, Buchanan C, Taboada EN, Zhang Y, Karmali MA, et al. (2009) In silico genomic analyses reveal three distinct lineages of Escherichia coli O157:H7, one of which is associated with hyper-virulence. BMC Genomics 10: 287.
31. Leopold SR, Magrini V, Holt NJ, Shaikh N, Mardis ER, et al. (2009) A precise reconstruction of the emergence and constrained radiations of Escherichia coli O157 portrayed by backbone concatenomic analysis. Proc Natl Acad Sci U S A 106: 8713-8718.
32. Robinson CM, Sinclair JF, Smith MJ, O'Brien A D (2006) Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc Natl Acad Sci U S A 103: 9667-9672.
33. Haack KR, Robinson CL, Miller KJ, Fowlkes JW, Mellies JL (2003) Interaction of Ler at the LEE5 (tir) operon of enteropathogenic Escherichia coli. Infect Immun 71: 384-392.
34. Barba J, Bustamante VH, Flores-Valdez MA, Deng W, Finlay BB, et al. (2005) A positive regulatory loop controls expression of the locus of enterocyte effacement-encoded regulators Ler and GrlA. J Bacteriol 187: 7918-7930.
35. Russell RM, Sharp FC, Rasko DA, Sperandio V (2007) QseA and GrlR/GrlA regulation of the locus of enterocyte effacement genes in enterohemorrhagic Escherichia coli. J Bacteriol 189: 5387-5392.
36. Friedberg D, Umanski T, Fang Y, Rosenshine I (1999) Hierarchy in the expression of the locus of enterocyte effacement genes of enteropathogenic Escherichia coli. Mol Microbiol 34: 941-952.
37. Laaberki MH, Janabi N, Oswald E, Repoila F (2006) Concert of regulators to switch on LEE expression in enterohemorrhagic Escherichia coli O157:H7: interplay between Ler, GrlA, HNS and RpoS. Int J Med Microbiol 296: 197-210.
38. Shin S, Castanie-Cornet MP, Foster JW, Crawford JA, Brinkley C, et al. (2001) An activator of glutamate decarboxylase genes regulates the expression of enteropathogenic Escherichia coli virulence genes through control of the plasmidencoded regulator, Per. Mol Microbiol 41: 1133-1150.
39. Klapproth JM, Scaletsky IC, McNamara BP, Lai LC, Malstrom C, et al. (2000) A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect Immun 68: 2148-2155.
40. Klapproth JM, Sasaki M, Sherman M, Babbin B, Donnenberg MS, et al. (2005) Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo. Infect Immun 73: 1441-1451.
41. Grys TE, Siegel MB, Lathem WW, Welch RA (2005) The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells. Infect Immun 73: 1295-1303.
42. Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073-1086.
43. de Sablet T, Bertin Y, Vareille M, Girardeau JP, Garrivier A, et al. (2008) Differential expression of stx2 variants in Shiga toxin-producing Escherichia coli belonging to seropathotypes A and C. Microbiology 154: 176-186.
44. Dowd SE, Williams JB (2008) Comparison of Shiga-like toxin II expression between two genetically diverse lineages of Escherichia coli O157:H7. J Food Prot 71: 1673-1678.
45. Herold S, Karch H, Schmidt H (2004) Shiga toxin-encoding bacteriophages-genomes in motion. Int J Med Microbiol 294: 115-121.
46. Los JM, Los M, Wegrzyn G, Wegrzyn A (2009) Differential efficiency of induction of various lambdoid prophages responsible for production of Shiga toxins in response to different induction agents. Microb Pathog 47: 289-298.
47. Serra-Moreno R, Jofre J, Muniesa M (2008) The CI repressors of Shiga toxinconverting prophages are involved in coinfection of Escherichia coli strains, which causes a down regulation in the production of Shiga toxin 2. J Bacteriol 190: 4722-4735.
48. Schmidt H, Beutin L, Karch H (1995) Molecular analysis of the plasmidencoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect Immun 63: 1055-1061.
49. Aldick T, Bielaszewska M, Zhang W, Brockmeyer J, Schmidt H, et al. (2007) Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium. Microbes Infect 9: 282-290.
50. Saitoh T, Iyoda S, Yamamoto S, Lu Y, Shimuta K, et al. (2008) Transcription of the ehx enterohemolysin gene is positively regulated by GrlA, a global regulator encoded within the locus of enterocyte effacement in enterohemorrhagic Escherichia coli. J Bacteriol 190: 4822-4830.
51. Dibb-Fuller MP, Best A, Stagg DA, Cooley WA, Woodward MJ (2001) An invitro model for studying the interaction of Escherichia coli O157:H7 and other enteropathogens with bovine primary cell cultures. J Med Microbiol 50: 759-769.
52. Knutton S, Baldwin T, Williams PH, McNeish AS (1989) Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli. Infect Immun 57: 1290-1298.
53. Kerr MK (2003) Linear models for microarray data analysis: hidden similarities and differences. J Comput Biol 10: 891-901.
54. Quackenbush J (2002) Microarray data normalization and transformation. Nat Genet 32 Suppl: 496-501.
55. Bergholz TM, Wick LM, Qi W, Riordan JT, Ouellette LM, et al. (2007) Global transcriptional response of Escherichia coli O157:H7 to growth transitions in glucose minimal medium. BMC Microbiol 7: 97.
56. R/MAANOVA http://research.jax.org/faculty/churchill/software/Rmaanova/index.html.
57. Cui X, Hwang JT, Qiu J, Blades NJ, Churchill GA (2005) Improved statistical tests for differential gene expression by shrinking variance components estimates. Biostatistics 6: 59-75.
58. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
59. Cummings L, Riley L, Black L, Souvorov A, Resenchuk S, et al. (2002) Genomic BLAST: custom-defined virtual databases for complete and unfinished genomes. FEMS Microbiol Lett 216: 133-138.
60. Perna NT, Plunkett G, 3rd, Burland V, Mau B, Glasner JD, et al. (2001) Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409: 529-533.
61. Kulasekara BR, Jacobs M, Zhou Y, Wu Z, Sims E, et al. (2009) Analysis of the genome of the Escherichia coli O157:H7 2006 spinach-associated outbreak isolate indicates candidate genes that may enhance virulence. Infect Immun.
62. Stevens MP, Wallis TS(29 August 2005) Chapter 8.3.2.4, Adhesins of Enterohemorrhagic Escherichia coli. In: A. Böck RCI, J.B. Kaper, F.C. Neidhardt, T. Nyström, K.E. Rudd, C.L. Squires, eds. EcoSal-Escherichia coli and Salmonella: cellular and molecular biology. http://www.ecosal.org. ed Washington, D.C.: ASM Press).